Literature DB >> 11096525

Thromboangiitis Obliterans (Buerger's Disease).

.   

Abstract

Thromboangiitis obliterans (TAO) is a devastating nonatherosclerotic disease that often leads to digit and limb loss as well as intractable ischemic rest pain. Patients with TAO are uniformly heavy users of tobacco. This disorder is characterized as a miscellaneous form of vasculitis affecting small- and medium-sized arteries and veins. TAO causes painful ischemic ulcers of the digits and unusually painful and inflammatory superficial thrombophlebitis. The key to early diagnosis of TAO is a high clinical index of suspicion in the appropriate patient scenario, exclusion of any other potential cause, abnormal results from an Allen's test, and arteriographic findings of segmental digital arterial occlusions with "corkscrew" collateral vessels. The primary and clearly most effective therapy for TAO is cessation of the use of all tobacco products, with avoidance of any environmental tobacco smoke inhalation. There has been recent enthusiasm for prostaglandin E therapy and the intramuscular injection of angiogenic growth factors. For patients in whom the disease is identified late or for those who are unable to discontinue cigarette smoking, however, a frequent result is multiple limb amputations.

Entities:  

Year:  2000        PMID: 11096525     DOI: 10.1007/s11936-000-0014-1

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  24 in total

1.  Plasminogen activators and plasminogen activator inhibitor 1 before and after venous occlusion of the upper limb in thromboangiitis obliterans (Buerger's disease).

Authors:  N A Choudhury; M H Pietraszek; T Hachiya; S Baba; S Sakaguchi; Y Takada; A Takada
Journal:  Thromb Res       Date:  1992-05-15       Impact factor: 3.944

2.  Urinary cotinine measurement in patients with Buerger's disease--effects of active and passive smoking on the disease process.

Authors:  M Matsushita; S Shionoya; T Matsumoto
Journal:  J Vasc Surg       Date:  1991-07       Impact factor: 4.268

3.  Landmark publication from the American Journal of the Medical Sciences, 'Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene'. 1908.

Authors:  Leo Buerger
Journal:  Am J Med Sci       Date:  2009-04       Impact factor: 2.378

4.  Nonatherosclerotic segmental arterial occlusion of the extremity.

Authors:  K Inada; Y Iwashima; A Okada; K Matsumoto
Journal:  Arch Surg       Date:  1974-05

5.  Buerger's disease: cigarette smoker disease may always be cured by medical therapy alone. Uselessness of operative treatment.

Authors:  F Corelli
Journal:  J Cardiovasc Surg (Torino)       Date:  1973 Jan-Feb       Impact factor: 1.888

6.  The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease).

Authors:  J W Olin; J R Young; R A Graor; W F Ruschhaupt; J R Bartholomew
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

7.  Current trends in thromboangiitis obliterans (Buerger's disease) in women.

Authors:  S Sasaki; M Sakuma; T Kunihara; K Yasuda
Journal:  Am J Surg       Date:  1999-04       Impact factor: 2.565

8.  Antiendothelial cell antibodies in thromboangiitis obliterans.

Authors:  J Eichhorn; D Sima; C Lindschau; A Turowski; H Schmidt; W Schneider; H Haller; F C Luft
Journal:  Am J Med Sci       Date:  1998-01       Impact factor: 2.378

9.  Intra-arterial streptokinase as adjuvant therapy for complicated Buerger's disease: early trials.

Authors:  E A Hussein; A el Dorri
Journal:  Int Surg       Date:  1993 Jan-Mar

10.  Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. The European TAO Study Group.

Authors: 
Journal:  Eur J Vasc Endovasc Surg       Date:  1998-04       Impact factor: 7.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.